Author

Feng Guo

Wuhan Union Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Amit M. MaityiD· 1 shared Anil K. SoodiD· 1 shared Ayden Berndt· 1 shared Esther NeediD· 1 shared Firas MourtadaiD· 1 shared Lydia J. WilsoniD· 1 shared Matthew Goff· 1 shared Neetu Singh· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Amit M. MaityORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

FOLR1-targeted Actinium-225-based Alpha-particle Therapy Eliminates Ovarian Cancer

Neetu Singh, Esther Need, Ayden Berndt, Matthew Goff, Lydia J. Wilson, Firas Mourtada, Feng Guo, Tara Mastren, Taslim Ahmed Al-Hilal, Anil K. Sood, Amit M. Maity, Scott C. Miller, Satoshi Minoshima, Shreya Goel, Sixiang Shi

This study demonstrates that FOLR1-targeted Actinium-225 alpha-particle therapy effectively treats ovarian cancer with high tumor regression and survival rates while minimizing toxicity.

Science Advances · Jun 24, 2026Peer-reviewedBioengineering